TransCelerate selects Veeva Vault SiteExchange

Veeva and TransCelerate collaborate to simplify document exchange in clinical trials between investigators and sponsors

The platform unlocks more time for research

TransCelerate, a non-profit organisation of global biopharmaceutical companies, has selected Veeva Vault SiteExchange for the Shared Investigator Platform (SIP).

The platform facilitates investigative site collaboration with multiple clinical trial sponsors. Veeva Systems create cloud-based software for the global life sciences industry.

Veeva Vault SiteExchange is a cloud application that will help sites consolidate study document requests, alerts, and notifications across sponsors in the TransCelerate-sponsored SIP.

Investigators can spend less time on administrative tasks and focus more on clinical research.

The TransCelerate SIP Initiative aims to provide the industry with a centralised platform that will be interoperable with various clinical solutions; streamline communications between investigators and sponsors; and reduce redundant requests during a trial.

TransCelerate chose Veeva Vault SiteExchange to simplify document access and exchange through the SIP.

Veeva Vault SiteExchange will improve efficiencies and allow clinical trial investigators, sites and participating sponsors to have immediate and centralised access to critical documents, eliminating one of the burdens that exists at investigator sites.

“The integration of Veeva Vault SiteExchange with the Shared Investigator Platform simplifies site administrative efforts, which is core to priorities to improve site experience,” said Janice Chang, Senior Vice President of global operations at TransCelerate.

“TransCelerate is doing exciting work to promote enhanced industry collaboration and introduce efficient ways companies can accelerate treatments to market,” said Jennifer Goldsmith, Senior Vice President of Veeva Vault strategy.

“We’re honored to help clinical sites and sponsors effectively manage trial documentation to get medicine to patients more quickly.”

Companies